Westlake Chemical Partners (WLKP)
(Delayed Data from NYSE)
$22.31 USD
-0.15 (-0.67%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $22.30 -0.01 (-0.04%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth D Momentum A VGM
Balance Sheet
Fiscal Year End for Westlake Chemical Partners LP falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 59 | 65 | 17 | 17 | 20 |
Receivables | 163 | 176 | 255 | 242 | 216 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 4 | 5 | 9 | 3 | 2 |
Other Current Assets | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 226 | 246 | 281 | 263 | 238 |
Net Property & Equipment | 944 | 990 | 1,044 | 1,051 | 1,103 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 141 | 130 | 150 | 37 | 46 |
Intangibles | 6 | 6 | 6 | 6 | 6 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 1,317 | 1,372 | 1,481 | 1,356 | 1,393 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 31 | 49 | 46 | 21 | 21 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 25 | 18 | 61 | 19 | 18 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 56 | 67 | 107 | 40 | 39 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 2 | 2 | 2 | 2 | 2 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 400 | 400 | 400 | 400 | 400 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 3 | 0 | 0 | 0 | 1 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 461 | 468 | 508 | 441 | 441 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 523 | 535 | 537 | 520 | 520 |
Capital Surplus | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | 0 | 0 | 0 | 0 | 0 |
Other Equity | 334 | 369 | 436 | 395 | 432 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 856 | 904 | 973 | 915 | 952 |
Total Liabilities & Shareholder's Equity | 1,317 | 1,372 | 1,481 | 1,356 | 1,393 |
Total Common Equity | 856 | 904 | 973 | 915 | 952 |
Shares Outstanding | 35.20 | 35.20 | 35.20 | 35.20 | 35.10 |
Book Value Per Share | 24.33 | 25.67 | 27.63 | 26.00 | 27.13 |
Fiscal Year End for Westlake Chemical Partners LP falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 66 | 56 | 59 | 66 | 59 |
Receivables | 161 | 163 | 163 | 161 | 157 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 4 | 5 | 4 | 4 | 3 |
Other Current Assets | 1 | 0 | 0 | 1 | 1 |
Total Current Assets | 232 | 224 | 226 | 231 | 221 |
Net Property & Equipment | 913 | 927 | 944 | 959 | 963 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 138 | 138 | 141 | 145 | 146 |
Intangibles | 6 | 6 | 6 | 6 | 6 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 1,288 | 1,295 | 1,317 | 1,342 | 1,336 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 28 | 23 | 31 | 44 | 39 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 22 | 20 | 25 | 31 | 27 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 50 | 43 | 56 | 76 | 66 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 2 | 2 | 2 | 2 | 2 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 400 | 400 | 400 | 400 | 400 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 3 | 3 | 3 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 454 | 447 | 461 | 480 | 468 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 519 | 521 | 523 | 525 | 528 |
Capital Surplus | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | 0 | 0 | 0 | 0 | 0 |
Other Equity | 316 | 328 | 334 | 336 | 340 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 835 | 848 | 856 | 861 | 868 |
Total Liabilities & Shareholder's Equity | 1,288 | 1,295 | 1,317 | 1,342 | 1,336 |
Total Common Equity | 835 | 848 | 856 | 861 | 868 |
Shares Outstanding | 35.20 | 35.20 | 35.20 | 35.20 | 35.20 |
Book Value Per Share | 23.72 | 24.10 | 24.33 | 24.47 | 24.66 |